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Computed tomography (CT)Abstract In daily practice, when multiple osteolytic lesions are seen on imaging studies, metastatic
bone disease is the first diagnostic impression. We herein present a case of a 45-year-old man, with-
out any known tumor, who was evaluated for multiple osteolytic lesions with a strong suspicion of
bone metastasis, but the radiological and biochemical findings suggested a hyperparathyroidism.
Therefore, whenever multiple osteolytic lesions are found in a patient without any known tumor,
metabolic bone diseases including hyperparathyroidism should be highly considered.
 2016TheEgyptian Society ofRadiology andNuclearMedicine. Production and hosting byElsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Brown tumors are focal reactive osteolytic lesions caused by
hyperparathyroidism (HTP) and represent the terminal stage
of the hyperparathyroidism-dependent bone pathology.
Nowadays, the manifestation of hyperparathyroidism withthese lesions is extremely rare in developed countries,
because of the early detection of the disease, using routine
laboratory examination and early treatment of that. These
benign lesions present similar radiologic findings as bone
metastasis, which makes the diagnosis difficult (1,2). Here,
we present a case of a man with bone pain and multiple
osteolytic lesions confused initially with bone metastasis.
The chondrocalcinosis seen on CT and the appearance of
some of the osteolytic lesions with sclerotic borders suggest
the possibility of hyperparathyroidism. Therefore, when a
patient presents with unexplained osteolytic lesions,
although metastatic malignancies should be ruled out first,
other differential diagnosis such as metabolic bone disease
including hyperparathyroidism should be kept in mind as
well, in order to reach an accurate diagnosis.
Fig. 1 Axial radiographs of the pelvis, demonstrating multiple osteolytic lesions with well-defined borders in femurs and right pubis.
Fig. 2 Pelvic CT (axial & coronal views), illustrating multiple osteolytic lesions, some of them have well-defined or sclerotic border (^),
while others are expansive with cortical destruction and associated soft tissue component (*). In addition there is chondrocalcinosis of the
symphysis pubis and the right hip (arrows).
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A 45-year-old man presented to the emergency department of
another center with pelvic pain after falling. The X-ray and
CT-scan revealed no fractures, but multiple osteolytic lesionswere found in the pelvic area (Figs. 1 and 2). The patient’s
medical history was not significant except for persistent pain
in thighs and hips for more than two years. He didn’t have
any significant family history. He was then referred to our hos-
pital under impression of bone metastasis. We reviewed the
Fig. 3 (A) PET/CT scan, reveals high uptake in a nodule in the inferior aspect of the thyroid’s left lobe. (B) Tc99m MIBI scintigraphy,
shows a left parathyroid nodule. (C) Histopathology image of right iliac bone lesion (Hematoxylin-eosin stain; Magnification 20), shows
multinucleated osteoclastic giant cells, but there aren’t any malignant cells.
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ple osteolytic lesions with variable appearances. Some had
well-defined or sclerotic borders while others were expansive
with cortical destruction and associated soft tissue mass
(Fig. 2). Another valued finding on CT-scan was chondrocal-
cinosis of the symphysis pubis (Fig. 2B) and the right hip
(Fig. 2C). Also CT-scan revealed a nodule in the inferior
aspect of the thyroid’s left lobe. Different pathologies includ-
ing hyperparathyroidism are associated with chondrocalci-
nosis. Therefore, analysis of serum calcium and parathyroid
hormone (PTH) level were performed.
Meanwhile the internal medicine service continued the
tumor diagnostic workup with the initial suspicion of metasta-
sis by referring the patient for a whole body positron emission
computed tomography (PET-CT).The PET scan showed
increased FDG-uptake in the osteolytic lesions and in the nod-
ule in the inferior aspect of the thyroid’s left lobe (Fig. 3A).
Laboratory studies revealed an elevated serum calcium level
of 15 mg/dl (normal range: 8, 7–10, 3) and elevated serum
parathormone level of 1462 pg/ml (normal range: 14–72). Con-
sidering possible hyperparathyroidism caused by a parathyroid
nodule, a parathyroid scintigraphy with Tc-99m sestamibi was
performed, which showed a focal increased uptake in inferior
left parathyroid gland (Fig. 3B).
At the same time, for the purpose of excluding malignan-
cies, a biopsy of the lesion, localized in the right iliac bone,
was performed. Pathologic analysis revealed a fibroblastic
stroma with multinucleated osteoclastic giant cell (Fig. 3C).
These cells may be present in true giant cell tumors, reparative
granulomas, and even brown tumors, but there were not
malignant cells. Thus, bone metastasis was ruled out. Consid-
ering radiological, pathological and laboratory test results, wereached the definitive diagnosis of brown tumors caused by
hyperparathyroidism. The patient underwent parathyroidec-
tomy and histopathological evaluation confirmed a parathy-
roid adenoma. After surgery, the PTH levels returned to
normal but the patient developed hungry bone syndrome with
severe hypocalcemia, requiring high doses of oral and intra-
venous calcium. After one year of follow up, the patient is still
receiving calcium supplementation, all osteolytic lesions are
reossified or healed and chondrocalcinosis maintained (Fig. 4).3. Discussion
This case report is of special interest because of the different
radiological appearances of the multiple osteolytic lesions,
which converged in brown tumors. Some of them had well-
defined or even sclerotic margins, while others were expansive
with cortical destruction and soft-tissue mass, suggesting an
aggressive bone tumor. In fact, some of the osteolytic lesions
could be confused with bone metastasis but the majority
remembered cysts or other benign lesions. The radiologic sim-
ilarities between brown tumors and other bone tumors, made it
difficult to reach the accurate diagnosis. A solitary brown
tumor might be confused with solitary bone cyst, aneurismal
bone cyst, giant cell tumor or giant cell reparative granuloma.
With multiple brown tumors, differential diagnosis includes:
osteolytic metastasis, multiple myeloma, multiple bone cysts,
etc. It is the presence of sclerotic margin that excludes metas-
tasis (3). In this case, the radiological appearance of some of
the osteolytic lesions and the additional finding of chondrocal-
cinosis suggested the possibility of hyperparathyroidism. It is
well known that hyperparathyroidism promoves deposits of
Fig. 4 Pelvic CT four month after treatment (axial & coronal views), illustrating osteoblastic response of bone lesions. The preoperative
lesions are transformed in blastics.
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In fact, the prevalence of chondrocalcinosis in patients with
primary hyperparathyroidism is higher than that in general
population (4,5), especially in patients with metabolic bone
disease due to hyperparathyroidism. This finding probably
reflects the fact that the chondrocalcinosis in hyperparathy-
roidism is associated with increased calcium and parathyroid
hormone concentration for a long time (6).
Brown tumors represent a reparative cellular process with
localized accumulation of fibrosis tissue and giant cells that
can replace bone and even produce osseous expansion. Radio-
graphically, these are osteolytic lesions with eccentric or corti-
cal location and margins usually well-defined. Most commonly
occur in facial bones and jaws, pelvis, ribs, femurs and other
long bones. Histopathologic findings consist of osteoclastic
resorption with cavities filed with fibrous tissue, giant cells,
hemosiderin deposits and macrophages (7). In this case the
variable aspect of osteolytic lesions, some of them with cortical
destruction and soft-tissue mass, mimicked a malignant tumor
and led to the biopsy of the lesion with soft-tissue mass in the
right iliac bone. This difference in the radiological aspect of
brown tumors could be explained by the difference in the time
of appearance of the lesions in the course of hyperparathy-
roidism. In fact the biopsy of the lesion with soft-tissue
component in right iliac bone ruled out malignancy and
demonstrated accumulation of osteoclastic multinucleated
giant cells. These cells are present in giant cell reparativegranuloma, giant cell tumor and also in brown tumors. After
resection of parathyroid adenoma, the follow-up CT showed
remineralization of the brown tumors with osteoblastic trans-
formation due to reversal of the parathyroid hormone. This
induces a stop in osteoclastic bone resorption with increased
skeletal usage of calcium. Therefore, the patient developed
the hungry bone syndrome due to hypocalcaemia. Hungry
bone syndrome refers to the rapid, profound (serum calcium
<2.1 mmol/l), and prolonged (longer than 4th day postopera-
tively) hypocalcaemia, and is exacerbated by suppressed
parathyroid hormone levels, which follows parathyroidectomy
for severe primary hyperparathyroidism. This phenomenon
occurs in patients who have developed bone disease preopera-
tively due to a chronic increase in bone resorption induced by
high levels of PTH (8). The treatment includes the administra-
tion of high doses of calcium. Duration of the treatment
depends on the symptoms and may last for up to 12 or more
months. The completion of bone remineralization occurs
1 year after parathyroidectomy.
4. Conclusion
The presence of multiple osteolytic lesions, some of them with
well defined or even sclerotic borders, while others are expan-
sive with soft-tissue component, and chondrocalcinosis, in a
patient without known primary tumor, are highly suggestive
of brown tumors induced by hyperparathyroidism. Although
Multiple brown tumors 541bone metastasis should be ruled out first, in this patient, the
metabolic bone disease including hyperparathyroidism should
be highly considered and therefore, serum calcium and PTH
levels should be checked before the whole set of tumor survey
is initiated.
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